Two Sigma Advisers’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Sell |
|
|||||
|
2025
Q1 | $480K | Buy |
|
|||||
|
2024
Q4 | $308K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $449K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $779K | Sell |
|
|||||
|
2023
Q1 | $2.72M | Sell |
|
|||||
|
2022
Q4 | $4.22M | Sell |
|
|||||
|
2022
Q3 | $5.64M | Buy |
|
|||||
|
2022
Q2 | $4.72M | Sell |
|
|||||
|
2022
Q1 | $5.54M | Sell |
|
|||||
|
2021
Q4 | $12M | Sell |
|
|||||
|
2021
Q3 | $21.2M | Sell |
|
|||||
|
2021
Q2 | $36.4M | Buy |
|
|||||
|
2021
Q1 | $25.8M | Buy |
|
|||||
|
2020
Q4 | $21.9M | Buy |
|
|||||
|
2020
Q3 | $2.16M | Buy |
|
|||||
|
2020
Q2 | $295K | Buy |
|